Macquarie Group »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Macquarie Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Macquarie Group from 13F filings

Historical chart of Macquarie Group investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Macquarie Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4M 2.1M 1.65
2025-06-30 $2.8M 2.2M 1.30
2025-03-31 $2.5M 2.2M 1.15

More positions owned by Macquarie Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Ishares Tr Mortge Rel Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Howmet Aerospace (HWM)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Macquarie Group

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
Morgan Stanley
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1